
News|Articles|December 1, 2023
AAO 2023: Intracanalicular dexamethasone insert using IRIS Registry
Author(s)David Hutton, Sheryl Stevenson
Benjamin Y Xu, MD, spoke with the Ophthalmology Times team about the real-world safety analysis of patients treated with intracanalicular dexamethasone insert using IRIS Registry at this year's American Academy of Ophthalmology meeting.
Advertisement
Benjamin Y Xu, MD, spoke with the Ophthalmology Times team about the real-world safety analysis of patients treated with intracanalicular dexamethasone insert using IRIS Registry at this year's American Academy of Ophthalmology meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
How AI is reshaping ophthalmology in 2025 and beyond
2
From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases
3
8 things to know about aflibercept 8 mg for retinal vascular disease
4
AI in ophthalmology research: Ethical implications for medical students
5












































